Urinary incontinence in prostate cancer patients treated with external beam radiotherapy Fulltext Access 5 Pages 2005
Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery Fulltext Access 5 Pages 2005
Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer Fulltext Access 5 Pages 2005
HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome Fulltext Access 5 Pages 2005
Long term results of non-surgical, exclusive strontium-/yttrium-90 beta-irradiation of pterygia Fulltext Access 5 Pages 2005
The bright but ephemeral life of a rainbow. A chronicle of seventeen years of intensive ESTRO-EU cooperation Fulltext Access 5 Pages 2005
A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas Fulltext Access 5 Pages 2005
The impact of organ motion on intestine doses and complication probabilities in radiotherapy of bladder cancer Fulltext Access 5 Pages 2005
Does More Aggressive Therapy Improve Outcomes in the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer? Fulltext Access 5 Pages 2005
Intensity-modulated radiotherapy as the boost or salvage treatment of nasopharyngeal carcinoma: The appropriate parameters in the inverse planning and the effect of patient's anatomic factors on the planning results Fulltext Access 5 Pages 2005
Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity Fulltext Access 5 Pages 2005
A phase II trial of low-dose total body irradiation and subcutaneous Interleukin-2 in metastatic melanoma Fulltext Access 5 Pages 2005
Reirradiation of nasopharyngeal carcinoma withintensity-modulated radiotherapy Fulltext Access 5 Pages 2005
The effects of tangential radiotherapy on lung clearance in breast cancer patients Fulltext Access 5 Pages 2005
Are external quality assurance (EQA) slide schemes a valid tool for the performance assessment of histopathologists? Fulltext Access 5 Pages 2005
A case of primary biliary cirrhosis accompanied with fibrinogen storage disease Fulltext Access 5 Pages 2005
Pure (non-papillary) serous cystadenoma of the epididymis: a histologic and immunohistochemical study Fulltext Access 5 Pages 2005
Emerging Data on IMiDs in the Treatment of Myelodysplastic Syndromes (MDS) Fulltext Access 5 Pages 2005
Clinical and quality of life responses to high-dose chemotherapy plus autologous stem cell transplantation in patients with multiple sclerosis: two case reports Fulltext Access 5 Pages 2005
Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action? Fulltext Access 5 Pages 2005
BM micrometastases and circulating tumor cells in breast cancer patients: where have we been, where are we now and where does the future lie? Fulltext Access 5 Pages 2005
Therapeutic potential of CD4+ CD25+ regulatory T cells in allogeneic transplantation Fulltext Access 5 Pages 2005
Making Unresectable Hepatic Colorectal Metastases Resectable-Does It Work? Fulltext Access 5 Pages 2005
Can Molecular Imaging Predict Response to Preoperative Chemoradiation in Patients with Rectal Cancer? A Fox Chase Cancer Center Prospective Experience Fulltext Access 5 Pages 2005
Morbidity and Mortality are not Increased After Induction Chemoradiotherapy Followed by Esophagectomy in Patients With Esophageal Cancer Fulltext Access 5 Pages 2005
Impact of Cyclin D1 A870G Polymorphism in Esophageal Adenocarcinoma Tumorigenesis Fulltext Access 5 Pages 2005
A case of primary ductal adenocarcinoma of the lacrimal gland: histopathological and immunohistochemical study Fulltext Access 5 Pages 2005
Response Assessments in Low-Risk and High-Risk Myelodysplastic Syndromes (MDS) Fulltext Access 5 Pages 2005
Development of Novel Chemotherapeutic Agents to Evade the Mechanisms of Multidrug Resistance (MDR) Fulltext Access 5 Pages 2005
The expanding role of interventional radiology in the supportive care of the oncology patient: From diagnosis to therapy Fulltext Access 5 Pages 2005
Combined Modality Trials in Unresectable Stage III Non-Small Cell Lung Cancer: The Cancer and Leukemia Group B Experience Fulltext Access 5 Pages 2005
Pulmonary Toxicity Associated With the Treatment of Non-Small Cell Lung Cancer and the Effects of Cytoprotective Strategies Fulltext Access 5 Pages 2005
Tumour staging using magnetic resonance imaging in clinically localised prostate cancer: relationship to biochemical outcome after neo-adjuvant androgen deprivation and radical radiotherapy Fulltext Access 5 Pages 2005
Idiopathic hypereosinophilic syndrome: a case evolving in B-lymphoblastic lymphoma Fulltext Access 5 Pages 2005
Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells Fulltext Access 5 Pages 2005
Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemia Fulltext Access 5 Pages 2005
Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection Fulltext Access 5 Pages 2005
Up-regulation of DNA methyltransferases DNMT1, 3A, and 3B in myelodysplastic syndrome Fulltext Access 5 Pages 2005
Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment Fulltext Access 5 Pages 2005
Dimethylsulfoxide induces upregulation of tumor suppressor protein PTEN through nuclear factor-κB activation in HL-60 cells Fulltext Access 5 Pages 2005
Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia Fulltext Access 5 Pages 2005
Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity Fulltext Access 5 Pages 2005
Redesign of thoracic surgical services within a cancer network-using an oncology focus to inform change Fulltext Access 5 Pages 2005
Identification of leukemia-associated antigens in chronic myeloid leukemia by proteomic analysis Fulltext Access 5 Pages 2005
Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck Fulltext Access 5 Pages 2005
Survival in high-grade glioma: a study of survival in patients unfit for or declining radiotherapy Fulltext Access 5 Pages 2005
Pre-operative Plasma Levels of Vascular Endothelial Growth Factor A, C and D in Patients with Colorectal Cancer Fulltext Access 5 Pages 2005
A Phase I Study of Moderate-dose Radiation Therapy and Weekly Gemcitabine in Patients with Locally Advanced Non-small Cell Lung Cancer Not Suitable for Radical Chemoradiation Therapy Fulltext Access 5 Pages 2005
Factors Influencing the Use of Single vs Multiple Fractions of Palliative Radiotherapy for Bone Metastases: A 5-Year Review Fulltext Access 5 Pages 2005
Critique 1: Collaborative Clinical Research on End-of-Life Care in Pediatric Oncology Fulltext Access 5 Pages 2005
E41. Dilemmas in management: The controversial role of chemotherapy in PS 2 advanced NSCLC Fulltext Access 5 Pages 2005
Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesions Fulltext Access 5 Pages 2005
Detection of autoantibodies to livin and survivin in Sera from lung cancer patients Fulltext Access 5 Pages 2005
Consensus report: Pretreatment minimal staging and treatment of potentially resectable malignant pleural mesothelioma Fulltext Access 5 Pages 2005
Site-related expression of metastasis-associated and signaling molecules in malignant mesothelioma-a new model for the study of tumor biology and disease progression Fulltext Access 5 Pages 2005
Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer Fulltext Access 5 Pages 2005
High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia Fulltext Access 5 Pages 2005
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma Fulltext Access 5 Pages 2005
Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer Fulltext Access 5 Pages 2005
Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen Fulltext Access 5 Pages 2005
Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter Fulltext Access 5 Pages 2005
Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer Fulltext Access 5 Pages 2005
Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation Fulltext Access 5 Pages 2005
Phase II pilot trial of gemtuzumab ozogamicin (GO) as first line therapy in acute myeloid leukemia patients age 65 or older Fulltext Access 5 Pages 2005
Persistence of various chromosomal aberrations in recipient cells during complete remission after bone marrow transplantation followed by graft rejection Fulltext Access 5 Pages 2005
Assessment and follow-up of the proportion of T315I mutant BCR-ABL transcripts can guide appropriate therapeutic decision making in CML patients Fulltext Access 5 Pages 2005
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute mye Fulltext Access 5 Pages 2005
Rituximab therapy of lymphoma is enhanced by orally administered (1 â 3),(1 â 4)-d-β-glucan Fulltext Access 5 Pages 2005
A morphometric approach for the evaluation of angiogenesis in acute lymphoblastic leukemia of childhood Fulltext Access 5 Pages 2005
Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia Fulltext Access 5 Pages 2005
Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells Fulltext Access 5 Pages 2005
Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: New insights into the biology of TNF-alpha giving new treatment opportunities-the role of bupropion Fulltext Access 5 Pages 2005